Sleep Medicine

From the Journals

OSA may provide cardioprotection

A trend toward increased OSA severity was seen as cTn-I levels decreased, in a study of patients admitted for acute coronary syndromes.

MD IQ

Conference Coverage

New narcolepsy drug passes phase 3 test

SAN DIEGO – Solriamfetol improved sleepiness scores, compared with placebo, and may have a low addiction risk.

Pages